Two pharmacokinetic methods are used primarily to assess systematic bioavailability of orally dosed water-soluble compounds in vivo, but there have been no direct comparisons of the estimates obtained. The "area under the curve" (AUC) method employs a single oral dose of probe compound(s) followed by multiple blood sampling to obtain plasma concentration time curves. Separate injection of probe(s) followed by multiple blood sampling is used to calculate fractional elimination rate (K el ) and distribution pool space (S). The "steady state feeding" method relies on ad lib. feeding of a marked diet, with a single blood sample taken to measure steady state feeding concentration of probe(s); K el is estimated from the decline in probe concentration in excreta after injection, with a single blood sample taken to estimate S. We compared these methods directly in the Australian red wattlebird (Anthochaera carnunculata), measuring absorption of 3 H-l-glucose. The K el values estimated using the steady state feeding protocol were significantly higher, and estimates of S and bioavailability consequently lower, compared with the AUC protocol. The AUC method relies on fewer assumptions and allows simultaneous comparisons of absorption by mediated and nonmediated (i.e., paracellular) mechanisms but cannot be easily applied to freely feeding animals. The steady state feeding method allows work with smaller species and exploration of the effects of feeding on nutrient uptake but requires careful attention to the validity of assumptions that increase error in the calculations.
Introduction
Water-soluble nutrients such as carbohydrates and amino acids are absorbed in the small intestine by both protein carriermediated (transcellular; e.g., via the Na ϩ -glucose cotransporter SGLT1) and nonmediated (i.e., paracellular) mechanisms (Hopfer 1987) . Paracellular uptake involves transfer between epithelial cells, across the tight junctions that constrain the movement of water and hydrophilic solutes between the cells (Ballard et al. 1995; Anderson 2001) . The nutritional significance of paracellular absorption was the subject of debate in the past, in part because differences in methodology made comparisons across studies and species problematic (McWhorter 2005) . Paracellular transport of glucose appears to account for a relatively small proportion of total glucose uptake (∼5%) in nonflying mammals such as rats (O'Rourke et al. 1995; Uhing and Kimura 1995) , dogs (Lane et al. 1999; Pencek et al. 2002 Pencek et al. , 2003 , and humans (Fine et al. 1993) . Recent studies using uniform methodology have shown convincingly, however, that small birds (Karasov and Cork 1994; Levey and Cipollini 1996; Afik et al. 1997; Chediack et al. 2001 Chediack et al. , 2003 Napier et al. 2008b ) and bats CaviedesVidal et al. 2008 ) rely extensively on nonmediated mechanisms of absorption. In these animals, paracellular nutrient uptake supplements carrier-mediated absorption, allowing them to maintain high digestive efficiency in spite of generally smaller intestines, lower absorptive surface area, and relatively rapid digesta throughput (Caviedes-Vidal et al. 2007 ).
Absorption of small, nontransported, metabolically inert, water-soluble probe molecules (e.g., stereoisomers of simple sugars such as l-glucose) is used to assess paracellular nutrient absorption McWhorter 2005; McWhorter et al. 2006; Caviedes-Vidal et al. 2007; Napier et al. 2008a Napier et al. , 2008b . This typically involves measuring the fraction of an oral dose of a probe that reaches the systemic circulation, known as the "fractional absorption" or "systemic bioavailability" (Gibaldi 1991) . Measurement of in vivo rates of absorption of paracellular probes relative to compounds absorbed via mediated mechanisms provides the most robust assessment of the nutritional significance of paracellular uptake . The primary pharmacokinetic protocol used to measure both extent and rate of absorption in vivo (hereafter termed the "area under the curve," or AUC, exper-imental protocol) involves delivering probe(s) in a single dose by oral gavage and separately by injection, followed by multiple blood samples to obtain blood plasma marker concentration time curves (Gibaldi and Perrier 1982) . The requirement for multiple blood samples over a short period of time restricts the use of this approach to animals above a certain body mass (∼60 g in birds).
A second pharmacokinetic protocol estimates the bioavailability as animals are feeding ad lib. at steady state on a diet containing the marked probe(s) (hereafter termed the "steady state feeding" experimental protocol). Fractional probe elimination rate and distribution pool size must be assessed after intramuscular or intravenous injection, which can be carried out simultaneously with steady state feeding by using alternately radiolabeled compounds or in a separate experimental trial. This may be done by measuring probe concentration in multiple small blood samples over time after injection or, making additional assumptions, based on marker appearance in excreta. This method allows only calculation of bioavailability but has the advantage that when elimination is assessed based on marker appearance in excreta, only one or two blood samples are required (depending on whether absorption and elimination parameters are measured simultaneously or in separate trials), allowing the method to be applied in animals that are too small to allow multiple blood sampling. Furthermore, the protocol allows for manipulation of the diet the animal is feeding on, allowing assessment of the effects of diet energy density or nutrient concentration on absorption. Since its adaptation by Karasov and Cork (1994) , the steady state feeding method has been the protocol of choice for assessing paracellular nutrient absorption in small species (McWhorter et al. 2006 ) and has also been adapted for studying intestinal water absorption and renal function (McWhorter and Martínez del Rio 1999; McWhorter et al. 2003 McWhorter et al. , 2004 Hartman Bakken et al. 2004; Hartman Bakken and Sabat 2006) .
Where the rate of probe elimination is to be assessed from its rate of appearance in excreta, an important assumption is that the rate of loss of marker from plasma equals that of its appearance in excreta (Karasov and Cork 1994; Hartman Bakken et al. 2004 ). Karasov and Cork (1994) showed that this was the case in nectarivorous rainbow lorikeets (Trichoglossus haematodus) by sampling both blood and excreta in the same birds after probe injection. Although the method has been widely used over the intervening years (e.g., McWhorter and Martínez del Rio 1999; McWhorter et al. 2003 McWhorter et al. , 2004 Hartman Bakken et al. 2004; Hartman Bakken and Sabat 2006; Napier et al. 2008b) , this assumption has not been tested in any species other than the rainbow lorikeet. There has been no direct comparison of these two pharmacokinetic protocols in the same species. In particular, we have no assessment of differences in pharmacokinetic parameters and bioavailability estimates generated. The aim of our study, therefore, was to compare these two experimental protocols in the nectarivorous red wattlebird (Anthochaera carnunculata, Meliphagidae), examining the methodology, assumptions, and benefits of each pharmacokinetic method.
We selected the red wattlebird because it is sufficiently large to allow repeated blood sampling to be carried out. We have also compared the digestive handling of sugars by the red wattlebird and rainbow lorikeet (the latter species examined by Karasov and Cork in establishment of the steady state feeding method) and recorded substantial differences between the species (Napier et al. 2008a) . In rainbow lorikeets, the bioavailability of d-glucose calculated using the standard AUC pharmacokinetic protocol was not significantly different from apparent assimilation efficiency calculated using a traditional mass-balance approach (Napier et al. 2008a) or from estimates based on the steady state feeding pharmacokinetic protocol (Karasov and Cork 1994) . However, in the red wattlebird, estimated bioavailability of d-glucose using the AUC protocol was erroneously low (∼57%), did not match apparent assimilation efficiency values established through mass-balance approach (∼99%), and logically should have exceeded values for the bioavailability of l-glucose (estimated at 92%-96%; Napier et al. 2008a ). The erroneously low values for bioavailability of d-glucose were interpreted as presystemic catabolism and/or sequestering of the marker in tissues, subsequently confirmed by using 3-O-methyl-d-glucose (∼90%), a nonmetabolizable d-glucose analogue that competes for the same cotransporters as d-glucose (Napier et al. 2008a) . The appearance of l-glucose in the bloodstream is also exceptionally fast in red wattlebirds: values had already peaked by the first blood sample at 2.5-5 min while the peak for l-glucose absorption in rainbow lorikeets was recorded around 45 min. These results highlight substantial differences in digestive handling of sugars by two nectarivorous birds of similar body size and are sufficient to warrant revisitation of the assumptions of the pharmacokinetic methodologies. We undertook this study to directly compare the two pharmacokinetic protocols and to determine whether the assumptions of the steady state feeding protocol can be correctly applied to nectarivorous birds, which have high rates of carbohydrate digestion and assimilation.
Material and Methods

Birds and Their Maintenance
Seven red wattlebirds (Anthochaera carnunculata, mean body mass g, g) were captured on m p 108 ‫ע‬ 8 range p 98-114 b the grounds of Murdoch University, Perth, Western Australia, by mist netting in August 2007. Birds were housed in individual cages (46 cm # 56 cm # 45 cm) in a controlled-environment room maintained at on a 12-h automatic lighting 21Њ ‫ע‬ 2ЊC regime with the photophase from 0600 to 1800 hours. Wattlebirds were fed a maintenance diet ad lib. consisting of Wombaroo powder (main sugar type present was sucrose; Wombaroo Food Products, Adelaide, South Australia) supplemented with additional sucrose (total content of ca. 25% w/w dry matter), mixed with water in inverted, stoppered syringes. Birds were acclimated to captivity and experimental conditions (i.e., handled regularly and exposed to experimental cages) for at least 3 wk before experiments. Experiments were separated by at least a week to ensure birds recovered from repeated blood samples and maintained weight. Body mass did not change significantly between trials. During experiments, birds were housed individually in opaque plastic cages (42 cm # 54 cm # 50 cm) with an automatic lighting regime as above and a one-way mirror to minimize disturbance during collection of excreta. All animal care procedures and experimental protocols adhered to Murdoch University Animal Ethics Committee regulations (AEC protocol R1137/05).
General Methods
In accordance with multiple previous studies (e.g., Karasov and Cork 1994; , we used radiolabeled l-glucose, an isomer of d-glucose that is biologically inert, not metabolized, and not absorbed by carriermediated mechanisms (Karasov and Cork 1994; McWhorter 2005) . l-glucose bioavailability was estimated using 3 H-l-glucose administered orally (by oral gavage or ad lib. feeding) and by intramuscular (IM) injection to each bird. The order of treatment given was randomly assigned within each experimental protocol, and each bird was tested with both methods. The quantity of solution administered by IM injection, oral gavage, or ad lib. feeding was measured by weighing the syringe or feeder before and after administration ‫10000.0ע(‬ g). Aliquot samples of all radiolabeled solutions were transferred to scintillation vials. Excreta samples were collected in glass microcapillary tubes immediately after being voided by birds, with exact time of excretion noted, and transferred to scintillation vials. Blood samples were collected in standard heparinized microhematocrit tubes, which were sealed with Cha Seal clay tube sealing compound (Chase Scientific Glass, Rockwood, TN), and centrifuged for 2-3 min at ∼9,000 g; harvested plasma samples were transferred to scintillation vials. All scintillation vials were weighed before and after addition of samples ‫10000.0ע(‬ g); 3 mL of liquid scintillation fluid was added (Ecoliteϩ, MP Biomedicals Australasia, Seven Hills, New South Wales), and then vials were counted in a scintillation spectrometer (Beckman LS6500 Liquid Scintillation Counter, Beckman Coulter, Fullerton, CA) for disintegrations per minute (dpm). These values were later normalized to sample mass (i.e., dpm [mg sample] Ϫ1 ).
Assessment of l-Glucose Bioavailability Based on the AUC Protocol
This method relies on single-dose administration of the probe(s) followed by a series of blood samples.
3 H-l-glucose was administered to red wattlebirds by oral gavage and IM injection in separate experiments, separated by at least 2 wk to ensure complete recovery from the process of repeated blood collection. Measurements began approximately 2.5 h after lights on. Maintenance diet was removed 20 min before the experiments.
Oral Administration. Birds were gavaged with 300 mL of a solution containing 1. ) and probe distribution pool size (S, mg plasma) of 3 H-l-glucose, birds were injected into the pectoralis muscle with 125 mL of a solution containing 0.8325 MBq of 3 H-lglucose and 175 mmol L Ϫ1 NaCl. The total osmolality of injection solutions was controlled at about 350 mmol kg Ϫ1 so that the solutions were approximately isosmotic with avian blood (Goldstein and Skadhauge 2000) . The values of K el and S were derived for each individual bird by linear fitting of lntransformed plasma 3 H-l-glucose concentration (C i ) over time after IM administration (t i ), with K el estimated from the slope of the line and S estimated from the y-intercept of the plasma plots, according to Karasov and Cork (1994) .
For both oral and IM administration, a brachial vein blood sample (∼50 mL) was collected before probe administration for background correction (t 0 ). Eight blood samples were similarly collected at times 2. 5, 5, 10, 20, 30, 45, 60 , and 120 min after administration. After the first hour of blood sampling (during which the birds were held in the hand and periodically offered maintenance diet from a feeder), birds were transferred to an experimental cage and received maintenance diet ad lib.
Bioavailability (f) was calculated by two methods (Gibaldi and Perrier 1982; Welling 1986 ). Equation (1) was required for comparison with the steady state feeding experiments, but equation (2) is the more traditional method for estimating bioavailability from repeated blood samples:
AUC /dose IM where AUC oral and AUC IM are the areas under the probe plasma concentration (C i ) versus time (t) curve for oral and IM treatments, respectively. The extent of absorption of the radiolabeled probe from t 0 to the last sampling point at 120 min (t n ) is represented by the area under the curve for this time period (AUCt n ), estimated as
The total area under the curve (AUC total ) represents the total amount of radiolabeled probe absorbed from time zero (t 0 ) to time infinity (t ϱ ). To extrapolate to t ϱ requires the calculation of AUCt nrϱ , which is estimated as H-lglucose concentration as described above.
Assessment of l-Glucose Bioavailability Based on the Steady State Feeding Protocol
The bioavailability of l-glucose was calculated as (Karasov and Cork 1994 )
The ingestion rate of radiolabeled l-glucose in food (I, dpm min Ϫ1 ) and the steady state concentration of radiolabel in plasma (P, dpm [mg plasma] Ϫ1 ) were determined through feeding trials, whereas the probe distribution pool size (S, mg plasma) and the elimination rate constant for removal of radiolabel (K el , min Ϫ1 ) were determined based on elimination of the radiolabel after IM injection. It is possible to collect data for all parameters simultaneously by using alternate radiolabels (e.g., 3 H-and 14 C-l-glucose as per Karasov and Cork 1994 ), but in our study feeding and injection trials were conducted separately (separated by at least 1 wk), both using 3 H-l-glucose. Before the commencement of the experiments, birds were allowed to feed ad lib. on a 400 mmol L Ϫ1 d-glucose diet for at least 6 h.
Oral Administration. Feeding trials commenced at 1500 hours when the bird was weighed and the unmarked diet solution was replaced with a syringe containing the equivalent diet that included 0.222 MBq mL Ϫ1 3 H-l-glucose. The ingestion rate of radiolabeled l-glucose (I, dpm min Ϫ1 ) was calculated from changes in the mass of the feeder syringe, with the exact time interval recorded for each individual bird from the moment feeding began until birds were removed from the cage to take a blood sample (∼3 h). Fresh excreta samples were collected at 10-15-min intervals for up to 3 h after oral administration to verify that the birds had reached steady state with regard to the absorption and excretion of the radiolabeled l-glucose. The steady state feeding concentration of radiolabeled l-glucose in plasma (P, dpm [mg plasma] Ϫ1 ) was determined in a single ∼50-mL blood sample taken from the brachial vein after birds had been feeding on the marked diet for approximately 3 h (exact time recorded for each bird).
IM Administration. At 1600 hours, each bird was weighed and then injected into the pectoralis muscle with 50 mL of solution containing 1.665 MBq of 3 H-l-glucose and 175 mmol L Ϫ1 NaCl. Birds were then allowed to feed ad lib. on unmarked 400 mmol L Ϫ1 d-glucose diet. Fresh excreta samples were collected immediately after being voided by birds (noting the exact time) for approximately 2 h after IM administration, and a single ∼50-mL blood sample was taken at the end of the excreta collection period.
The value of K el for the steady state feeding method was derived for each individual bird by three methods. First, K el was estimated as the linear slope of ln-transformed excreta lglucose concentrations over time after IM administration (Karasov and Cork 1994; method A). Second, K el was estimated from nonlinear curve fitting of excreta l-glucose concentrations (not ln-transformed) over time (method B), or, third, these data were edited to remove some initial data points for each individual where the differences between consecutive excreta l-glucose concentrations (dpm [mg excreta] Ϫ1 ) were at least five times higher than the differences between subsequent data points and nonlinear curve fitting was repeated (method C). This method of editing initial data may be justified because of disturbance of birds after handling for injections: these data may be unreliable since some individuals do not immediately return to normal rates of feeding and excretion, resulting in erratic and erroneous initial excreta marker concentrations that do not meet the required assumptions of normality and constant variance for model fitting. We estimated S using K el values calculated based on appearance of marker in excreta coupled with marker concentration in the single blood sample to calculate the theoretical l-glucose concentration at t 0 , which was then inversed to obtain distribution space (McWhorter et al. 2006) .
Statistical Analysis and Nonlinear Curve Fitting
Nonlinear curve fitting by the Marquardt-Levenberg algorithm (SYSTAT Software, SigmaPlot for Windows, San Jose, CA; Marquardt 1963) was used to assess plasma or excreta l-glucose elimination data. The following mono-and biexponential models were compared when analyzing the curves of concentrations (C) of l-glucose over time (t), where C 0 is the intercept (dpm [mg plasma] Ϫ1 ):
0 Ϫat Ϫbt C p ae ϩ be .
Model fits were compared by F-tests according to Motulsky and Ransnas (1987) , where the residual sum of squares and the numbers of parameters in each model are used to compute the F ratio, which tests for significant differences in the goodness of fit of the two models to the same data. We report the largest F values and the smallest P values of the six individual birds in each case. Numerical data are presented as ( mean ‫ע‬ SD n p number ). Although the data shown in figure 1a are mean of animals values, all calculations and statistical analyses were performed on data for individual birds. Bioavailability and other proportional data were arcsine square root transformed before statistical analysis (Sokal and Rohlf 1995) . Results were analyzed by repeated-measures ANOVA. Statistical significance was accepted at . a ! 0.05 
Results
Assessment of l-Glucose Bioavailability Based on the AUC Protocol
Plasma l-glucose concentration equilibrated rapidly after IM injection, with the average concentration in plasma peaking at 5 min, indicating little to no extended lag for distribution from the pectoralis muscle into the blood (fig. 1a) . After IM administration, the relationship between ln-transformed l-glucose concentrations in plasma (dpm mg Ϫ1 ) versus time was approximately linear ( , ; fig. 1b ), implying 2 R 1 0.94 P ! 0.001 single-compartment elimination kinetics. Single-compartment elimination kinetics were subsequently confirmed by nonlinear curve fitting; for six out of seven cases, l-glucose elimination data did not fit a biexponential model significantly better than a monoexponential model (for six cases, all , ). F ! 0.09 P 1 0.91 The elimination constant K el and probe distribution space S estimates derived from ln-transformed IM data are given in table 1.
After oral gavage, average l-glucose concentration in plasma peaked at 10 min ( fig. 1a) and declined exponentially thereafter. There was a significant difference between dose-corrected AUC oral and AUC IM (  ; table 1 ). l-glucose bioavail-P p 0.001 ability estimated by equation (1) ( ) was not sig-75.0% ‫ע‬ 7.6% nificantly different from that estimated by equation (2) ( ; ) . 83.2% ‫ע‬ 7.4% P p 0.18
Assessment of l-Glucose Bioavailability Based on the Steady State Feeding Protocol
Average steady state feeding plasma l-glucose concentration (P) was relatively high (table 1) in comparison to background (raw values ranged from 320 to 1,365 dpm), indicating substantial absorption of 3 H-l-glucose. Steady state feeding was verified by confirming that 3 H-l-glucose concentration in excreta was constant over time when animals were feeding on the marked diet. After animals had recovered from handling, all birds did feed at a steady state with regard to radiolabel ingestion and excretion by 90 min ( ,
2 R ! 0.25 P 1 0.30 After IM administration, the relationship between ln-transformed l-glucose concentrations from excreta (dpm mg Ϫ1 ) versus time were approximately linear ( , ; fig.   2 R 1 0.83 P ! 0.001 1c), implying single-compartment elimination kinetics for 3 Hl-glucose. The relationship between nonlinear curve fitting of excreta l-glucose concentrations (not ln-transformed) over time was deemed to follow single-compartment elimination kinetics (Motulsky and Ransnas 1987) , whether using all of the data (method B) or the edited data (method C). transformed excreta 3 H-l-glucose concentration data (method A) or nonlinear monoexponential model fits of all nontransformed data (method B) or edited data (method C, where the first data points were selectively removed; see "Material and Methods"). Superscripts refer to significant differences between methods (uppercase letters: differences in AUC between the administration routes; numbers: differences between the three SSF methods). For method B, in five out of seven cases a biexponential model did not fit l-glucose elimination data significantly better than a monoexponential model ( , ). For F ! 1.27 P 1 0.30 method C, in six out of seven cases a biexponential model did not fit l-glucose elimination data significantly better than a monoexponential model ( , ). F ! 0.02 P 1 0.98 There were significant differences in the estimates of K el and S derived through different methods and substantial differences in the variability of these data according to the method of calculation (see table 1 for values). Therefore, S values as a percent of body mass also differed between the methods (AUC:
; SSF method A: ; method B: 19.67% ‫ע‬ 3.01% 8.75% ‫ע‬ 5.44% ; method C:
). 2.71% ‫ע‬ 2.52% 17.3% ‫ע‬ 12.4%
Comparison of Experimental Protocols
Values of K el estimated as the slope of the relationship between ln-transformed excreta l-glucose concentration versus time (method A) derived through the steady state feeding protocol were higher than those estimated from the AUC method (table  1; ). Subsequently, S ( ) and f for l-glucose P p 0.023 P p 0.004 ( ) values were around half the values estimated from P p 0.001 the AUC method and were far less variable (table 1) .
The use of nonlinear curve fitting to raw excreta l-glucose concentration values (method B) made these discrepancies far worse (table 1) , and only by selectively editing these data (method C; see "Material and Methods" for criteria) were the values similar to those estimated using the AUC method (table  1) , although we note the high degree of variability in these edited data.
Discussion
The number of studies that have applied the steady state feeding pharmacokinetic protocol has grown recently because this method allows the researcher to work with small animals that could not withstand repeated blood sampling. Despite its wide application, there have been few studies that have critically assessed whether studies in animals meet the assumptions of the method or compare these data with those derived through the standard AUC pharmacokinetic protocol. Fundamentally, both protocols rely on the calculation of K el . We found that K el was significantly higher and S subsequently lower for the steady state feeding compared with the AUC protocol. Consequently, estimates of l-glucose bioavailability derived from the steady state feeding protocol were lower than estimates derived through the AUC protocol (unless the data were selectively edited). In this discussion, we explore the assumptions and advantages of these methods.
In addition to being the more robust method of estimation, the primary advantage of the AUC pharmacokinetic protocol is that it allows simultaneous comparison of the extent and rate of absorption of passively and actively absorbed probe molecules in vivo . This method therefore provides reliable evidence regarding the nutritional significance of paracellular absorption (e.g., the proportional contribution of paracellular to total glucose uptake). Calculations by this method can also be made with relatively few assumptions about kinetics of elimination or number of distribution pools (Welling 1986 ). Elimination of nonmetabolized probes (e.g., l-glucose and the actively transported glucose analogue 3-O-methyl-d-glucose) is by renal filtration, and because probe concentration is measured directly in blood, plasma marker concentration is influenced primarily by glomerular filtration rate (GFR). However, the disadvantage is that the protocol requires repeated blood samples to be collected over a relatively short time period.
The steady state feeding pharmacokinetic protocol, with probe elimination determined based on concentration in excreta, was validated by Karasov and Cork (1994) so that it could be applied in small birds, from which multiple blood samples cannot be drawn. This has proven to be a distinct advantage of this protocol, and it has been widely applied recently (McWhorter and Martínez del Rio 1999; McWhorter et al. 2003 McWhorter et al. , 2004 McWhorter et al. , 2006 Hartman Bakken et al. 2004; Hartman Bakken and Sabat 2006; Napier et al. 2008b ). Another advantage is that this method may be used to study the effects of diet energy density on the extent of paracellular absorption. For example, recent studies using steady state feeding methods in hummingbirds (McWhorter et al. 2006) , honeyeaters, and sunbirds (Napier et al. 2008b ) have shown that l-glucose bioavailability increases with an increase in diet energy density, most likely related to a concomitant increase in digesta retention time (Lopez-Calleja et al. 1997) .
Where animals are too small to withstand repeated blood sampling, the fractional rate of elimination of the probe from plasma has been estimated by its appearance in excreta. The primary assumption of this method is that the rate of loss of marker from plasma equals that of its appearance in excreta. Karasov and Cork (1994) showed that this was the case in nectarivorous rainbow lorikeets by sampling both blood and excreta in the same birds simultaneously after probe injection. Estimates of K el in our study were higher for the steady state feeding protocol (cf. values for the AUC protocol in table 1), revealing a faster rate of appearance of the probe in excreta than predicted from its removal from the bloodstream established via the AUC pharmacokinetic protocol. That is, red wattlebirds handle and eliminate l-glucose faster when feeding at a steady rate than under the AUC protocol (where they had feed withdrawn 20 min before the experiment and fed very little during the first hour of the experiment). Elimination of l-glucose in the steady state feeding protocol (based on appearance of marker in excreta) is influenced by GFR, renal fractional water recovery (FWR), and rate of digesta passing through the intestine (McWhorter et al. 2003) . FWR is responsive to reduced water intake rate in red wattlebirds (Goldstein and Bradshaw 1998) and other nectarivorous birds (Hartman Bakken et al. 2004; McWhorter et al. 2004) while GFR has been shown to be responsive to more extensive water shortage (e.g., due to nocturnal fasting) in hummingbirds (Hartman Bakken et al. 2004; Hartman Bakken and Sabat 2006) ; renal function in the nectarivorous birds studied to date may therefore be slowed or completely stop in response to reduced food (i.e., water) intake. When the birds are feeding ad lib. (i.e., under the steady state feeding protocol), they rapidly eliminate waste materials through their kidneys, but when they are not feeding, it is likely that there is reduction or suspension of renal function. It is therefore not surprising that the estimated rate of loss of marker from plasma, calculated when the birds are not feeding, does not match its appearance in excreta calculated when they are feeding ad lib.
Because of differences in estimations of K el , S estimates derived through the steady state feeding protocol (8.75% ‫ע‬ of body mass) were considerably lower than those esti-5.4% mated through the AUC pharmacokinetic protocol ( of body mass) and also lower than previously 19.67% ‫ע‬ 3.01% reported (∼20%-25% of body mass) for several other avian species over a range of body mass (Karasov and Cork 1994; Levey and Cipollini 1996; Afik et al. 1997; Hartman Bakken et al. 2004) . Therefore, the low values of S estimates as a percentage of body mass are considered to be suspect. Distribution pool size estimates rely on estimates of K el , and therefore the discrepancy in values for S are likely to similarly reflect renal function, potential postrenal modification of urine, and mixing of intestinal contents with urine.
The calculation of bioavailability relies heavily on estimates of K el and consequently S, and we have demonstrated that these measures are extremely sensitive to the mathematical method used to calculate them. Standard pharmacokinetic methods suggest that these values should be calculated from the relationship of ln-transformed values of probe concentration (in plasma or excreta) against time, and we believe that this is the most robust and objective approach to fitting mathematical functions to these types of data, especially when obtained from probe appearance in excreta. However, for the steady state feeding method, these calculations resulted in differing estimates of K el and consequently S that were around half those estimated by the AUC method. Nonlinear model fitting to raw (i.e., not ln-transformed) values results in greater error in the estimates of K el and S. A large proportion of this discrepancy apparently results from the first data points (i.e., the first few excreta collected once the animal is returned to its cage to feed), since elimination of those data with high C i values (where the difference between consecutive excreta concentrations were at least five times higher than the differences between subsequent data points) resulted in estimates of K el and S that were more similar to those derived using the AUC protocol. The steady state pharmacokinetic protocol is sensitive to the assumption that animals are feeding in steady state with regard to probe absorption and elimination. Some individuals did not return to feed immediately after they had been handled for injections, violating the assumption of steady state feeding, and consequently they displayed a reduced excretion rate for up to 40 min after return to cages. If possible, future studies should take care to record the time at which animals return to feeding, which may allow consideration of whether an individual violates the assumption of steady state feeding.
Finally, these pharmacokinetic mathematical calculations assume that elimination follows single-compartment kinetics, depicting the body as a single, kinetically homogenous unit (Gibaldi and Perrier 1982) . The assumption of single-compartment elimination kinetics appears to be valid for elimination of l-glucose based on concentration in both excreta and plasma for all species studied to date. Further, Karasov and Cork (1994) argued that changing the assumption about the number of compartments that influence probe elimination tends to cause counterbalancing changes in the slope (elimination rate constant, K el ) and intercept (inverse of distribution pool size S, when concentrations are dose corrected), so neither pharmacokinetic method is especially sensitive to deviations to this assumption.
Conclusions
Our results highlight the sensitivity of the steady state feeding pharmacokinetic protocol to violations of its primary assumption that birds are feeding in a steady state. The validity of assumptions associated with these protocols is critical in the calculation of pharmacokinetic parameters and, as such, need to be addressed when planning experiments and interpreting results. The use of mathematical models requiring assumptions that may be difficult to justify should be reconsidered wherever possible (Wade 1985) . It is not possible to compare the two methods for every new species (e.g., where the animal is too small to take repeated blood samples from), and we are not suggesting that this is required. However, acknowledgment of the limitations and validations of these two pharmacokinetic protocols will be an important step toward collecting valid data, while understanding these limitations will ensure that researchers carefully consider their experimental design. It is difficult to determine the magnitude of the potential margin of error across studies, since this is likely to vary greatly between species according to their responses to the different experimental protocols.
Each method has advantages and disadvantages, and these will be important in determining the experimental design selected for future studies. The standard pharmacokinetic AUC protocol provides the most robust estimates of bioavailability because it relies on fewer assumptions and also has the advantage of allowing calculation of probe absorption rates. However, because the birds do not feed ad lib. during the experiment, it should be recognized that potential changes in renal function may influence the estimates derived through this process. This is therefore not particularly useful for species that may shut down GFR during times of not feeding (e.g., nectarivorous species) because the data collected are not likely to reflect how the animals would cope with their diet under natural conditions.
On the other hand, the steady state feeding protocol provides estimates in unrestrained birds that are feeding ad lib. (assuming this condition can be met) and allows exploration of the effects of nutrient concentration and osmolality on paracellular permeability and nutrient uptake. The problem of how and when animals recommence feeding after disturbance plays a significant role in altering the initial data points collected and therefore estimates of K el and S. Habituating individual animals to handling may serve to reduce some of these issues, although we have found that some individuals, despite repeated attempts, still do not recommence feeding within sufficient time to yield reliable estimates (silvereyes Zosterops lateralis; K. Napier, unpublished data). It is probably advisable, therefore, to eliminate such individuals from further analyses since they do not yield physiologically relevant data. Species that naturally have a low food intake rate may be less likely to violate the conditions of steady state feeding than animals with a high food intake rate (although they would likely yield more variable data if the conditions of steady state feeding were not adequately met). Both protocols, therefore, have their advantages and application in the study of digestive physiology.
